Sheng Matilda H-C, Lau Kin-Hing William, Lakhan Ram, Ahmed Abu Shufian Ishtiaq, Rundle Charles H, Biswanath Patra, Baylink David J
Regenerative Medicine Division, Department of Medicine, Loma Linda University School of Medicine, Loma Linda, California.
Musculoskeletal Disease Center, Jerry L. Pettis Memorial Veterans Affairs Medical Center, Loma Linda, California.
Endocrinology. 2017 Apr 1;158(4):714-729. doi: 10.1210/en.2016-1379.
The present study was undertaken to determine the mechanism whereby calcitropic hormones and mesenchymal stem cell progeny changes are involved in bone repletion, a regenerative bone process that restores the bone lost to calcium deficiency. To initiate depletion, weanling mice with a mixed C57BL/6 (75%) and CD1 (25%) genetic background were fed a calcium-deficient diet (0.01%) for 14 days. For repletion, the mice were fed a control diet containing 1.2% calcium for 14 days. Depletion decreased plasma calcium and increased plasma parathyroid hormone, 1,25(OH)2D (calcitriol), and C-terminal telopeptide of type I collagen. These plasma parameters quickly returned toward normal on repletion. The trabecular bone volume and connectivity decreased drastically during depletion but were completely restored by the end of repletion. This bone repletion process largely resulted from the development of new bone formation. When bromodeoxyuridine (BrdU) was administered in the middle of depletion for 3 days and examined by fluorescence-activated cell sorting at 7 days into repletion, substantial increases in BrdU incorporation were seen in several CD105 subsets of cells of osteoblastic lineage. When BrdU was administered on days 1 to 3 of repletion and examined 11 days later, no increases in BrdU were seen in these subsets. Additionally, osteocytes that stained positively for BrdU were increased during depletion. In conclusion, the results of the present study have established a unique regenerative mechanism to initiate bone repair during the bone insult. Calcium homeostatic mechanisms and the bone repletion mechanism are opposing functions but are simultaneously orchestrated such that both endpoints are optimized. These results have potential clinical relevance for disease entities such as type 2 osteoporosis.
本研究旨在确定促钙激素和间充质干细胞后代变化参与骨补充的机制,骨补充是一种再生骨过程,可恢复因钙缺乏而流失的骨量。为引发骨量减少,将具有混合C57BL/6(75%)和CD1(25%)遗传背景的断奶小鼠喂食低钙饮食(0.01%)14天。为进行骨补充,给小鼠喂食含1.2%钙的对照饮食14天。骨量减少导致血浆钙降低,血浆甲状旁腺激素、1,25(OH)2D(骨化三醇)和I型胶原C末端肽增加。这些血浆参数在骨补充时迅速恢复正常。骨小梁体积和连通性在骨量减少期间急剧下降,但在骨补充结束时完全恢复。这种骨补充过程主要源于新骨形成的发展。当在骨量减少中期给予溴脱氧尿苷(BrdU)3天,并在骨补充7天时通过荧光激活细胞分选进行检测时,在成骨细胞谱系的几个CD105细胞亚群中观察到BrdU掺入量大幅增加。当在骨补充的第1至3天给予BrdU并在11天后进行检测时,在这些亚群中未观察到BrdU增加。此外,在骨量减少期间,BrdU染色阳性的骨细胞增加。总之,本研究结果建立了一种独特的再生机制,以在骨损伤期间启动骨修复。钙稳态机制和骨补充机制是相反的功能,但同时协调运作,以使两个终点都得到优化。这些结果对于2型骨质疏松症等疾病实体具有潜在的临床意义。